InvestorsHub Logo
Followers 1
Posts 54
Boards Moderated 0
Alias Born 03/30/2015

Re: StocksAnonymous post# 75564

Wednesday, 05/13/2015 9:10:09 AM

Wednesday, May 13, 2015 9:10:09 AM

Post# of 80868
Musclepharm switching manufacturing facilities definitley came into play in creating this backlog, and honestly it comes down on management. Management should have never allowed this number to get so big. This backlog is non-realized sales which i'm sure is leading to missed opportunity at the consumer level. If GNC places an order for a product and it's not in that store for 2 weeks, all the consumers who came in looking for that product i'm sure had to settle for something else or go elsewhere. On the flip side the product can't promote itself on the shelves to a customer who has never tried or came into the store looking to purchase without 100% direction on what they wanted to buy. It's hindering growth and hopefully something that is already fixed in Q2.